Europe — EMA
Bonalfa (Tacalcitol Monohydrate)
Bonalfa is a topical medication containing Tacalcitol Monohydrate, used for skin conditions. It is manufactured by Isdin Laboratorio Farmaceutico Unipessoal Lda
Request sourcing
What is Tacalcitol Monohydrate?
Bonalfa is a topical medication containing Tacalcitol Monohydrate, used for skin conditions. It is manufactured by Isdin Laboratorio Farmaceutico Unipessoal Lda. in the EU.
What is Tacalcitol Monohydrate used for?
Bonalfa is primarily used for cutaneous applications to manage skin conditions. Tacalcitol Monohydrate, the active ingredient, is often applied to address specific dermatological issues. Users may wonder, 'What is Bonalfa used for?' It is typically recommended for conditions that require localized treatment.
What are the side effects of Tacalcitol Monohydrate?
When applied to the skin, Bonalfa may help improve the appearance and condition of affected areas. Users might experience noticeable changes as the medication works on the skin. Common effects include improvements in skin texture and relief from discomfort.
What precautions apply to Tacalcitol Monohydrate?
Bonalfa should be used as directed to avoid potential irritation. It is important to follow the instructions provided by healthcare professionals. Users should be cautious when applying the medication to sensitive areas of the skin.
What does Tacalcitol Monohydrate interact with?
Bonalfa may interact with other topical treatments. Users should inform their healthcare provider about all medications they are using. Avoid combining Bonalfa with other skin treatments without professional advice.



